Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597680 | SCV000705887 | likely benign | not specified | 2017-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697393 | SCV000722330 | likely benign | not provided | 2018-05-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000863467 | SCV001004134 | likely benign | X-linked myopathy with postural muscle atrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001697393 | SCV001471004 | likely benign | not provided | 2019-12-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002404606 | SCV002714866 | likely benign | Cardiovascular phenotype | 2019-09-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |